Opposing effects of CXCR3 and CCR5 deficiency on CD8+ T cell-mediated inflammation in the central nervous system of virus-infected mice

Journal of Immunology

Volumn 175, Issue 3, 2005, Pages 1767-1775

  De Lemos, Carina ^a   Christensen, Jeanette Erbo ^a   Nansen, Anneline ^a   Moos, Torben ^a   Lu, Bao ^b   Gerard, Craig ^b   Christensen, Jan Pravsgaard ^a   Thomsen, Allan Randrup ^a,c  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

^b BOSTON CHILDREN S HOSPITAL   (United States)

^c UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

CD8 ANTIGEN; CHEMOKINE RECEPTOR CCR5; CHEMOKINE RECEPTOR CXCR3;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BRAIN; BRAIN INFECTION; CELL DAMAGE; CELL INVASION; CENTRAL NERVOUS SYSTEM; CEREBROSPINAL FLUID; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; ENCEPHALITIS; IMMUNE RESPONSE; IMMUNITY; INFECTION CONTROL; INFLAMMATION; LYMPHOCYTIC CHORIOMENINGITIS VIRUS; MONONUCLEAR CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; VIRUS INFECTION;

EID: 22544462497     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.175.3.1767     Document Type: Article

References (46)

1. Hickey, W. F. 2001. Basic principles of immunological surveillance of the normal central nervous system. Glia 36: 118-124.
2. Lowenstein, P. R. 2002. Immunology of viral-vector-mediated gene transfer into the brain: an evolutionary and developmental perspective. Trends Immunol. 23: 23-30.
3. Ransohoff, R. M., P. Kivisakk, and G. Kidd. 2003. Three or more routes for leukocyte migration into the central nervous system. Nat. Rev. Immunol. 3: 569-581.
4. Ransohoff, R. M. 1999. Mechanisms of inflammation in MS tissue: adhesion molecules and chemokines. J. Neuroimmunol. 98: 57-68.
5. Zhang, G. X., C. M. Baker, D. L. Kolson, and A. M. Rostami. 2000. Chemokines and chemokine receptors in the pathogenesis of multiple sclerosis. Mult. Scler. 6: 3-13.
6. Trebst, C., and R. M. Ransohoff. 2001. Investigating chemokines and chemokine receptors in patients with multiple sclerosis: opportunities and challenges. Arch. Neurol. 58: 1975-1980.
7. + T cells are increased in multiple sclerosis and their ligands MIP-1α and IP-10 are expressed in demyelinating brain lesions. Proc. Natl. Acad. Sci. USA 96: 6873-6878.
8. Sorensen, T. L., M. Tani, J. Jensen, V. Pierce, C. Lucchinetti, V. A. Folcik, S. X. Qin, J. Rottman, F. Sellebjerg, R. M. Strieter, J. L. Frederiksen, and R. M. Ransohoff. 1999. Expression of specific chemokines and chemokine receptors in the central nervous system of multiple sclerosis patients. J. Clin. Invest. 103: 807-815.
9. Sorensen, T. L., C. Trebst, P. Kivisakk, K. L. Klaege, A. Majmudar, R. Ravid, H. Lassmann, D. B. Olsen, R. M. Strieter, R. M. Ransohoff, and F. Sellebjerg. 2002. Multiple sclerosis: a study of CXCL10 and CXCR3 co-localization in the inflamed central nervous system. J. Neuroimmunol. 127: 59-68.
10. Giunti, D., G. Borsellino, R. Benelli, M. Marchese, E. Capello, M. T. Valle, E. Pedemonte, D. Noonan, A. Albini, G. Bernardi, et al. 2003. Phenotypic and functional analysis of T cell homing into the CSF of subjects with inflammatory diseases of the CNS. J. Leukocyte Biol. 73: 584-590.
11. + T cells in the cerebrospinal fluid of multiple sclerosis patients and control individuals. Clin. Exp. Immunol. 79: 15-20.
12. + T cells dominate the T cell infiltrate in active multiple sclerosis lesions as shown by micromanipulation and single cell polymerase chain reaction. J. Exp. Med. 192: 393-404.
13. + T cells in a model for multiple sclerosis. J. Exp. Med. 194: 669-676.
14. Cerwenka, A., T. M. Morgan, A. G. Harmsen, and R. W. Dutton. 1999. Migration kinetics and final destination of type 1 and type 2 CD8 effector cells predict protection against pulmonary virus infection. J. Exp. Med. 189: 423-434.
15. Thomsen, A. R., A. Nansen, A. N. Madsen, C. Bartholdy, and J. P. Christensen. 2003. Regulation of T cell migration during viral infection: role of adhesion molecules and chemokines. Immunol. Lett. 85: 119-127.
16. + T cells trafficking to cerebrospinal fluid in HIV-1 infection. J. Infect. Dis. 189: 2202-2212.
17. + T cells. Immunol. Today 11: 55-59.
18. Allan, J. E., J. E. Dixon, and P. C. Doherty. 1987. Nature of the inflammatory process in the central nervous system of mice infected with lymphocytic choriomeningitis virus. Curr. Top. Microbiol. Immunol. 134: 131-143.
19. Christensen, J. E., A. Nansen, T. Moos, B. Lu, C. Gerard, J. P. Christensen, and A. R. Thomsen. 2004. Efficient T cell surveillance of the CNS requires expression of the CXC chemokine receptor 3. J. Neurosci. 24: 4849-4858.
20. Glass, W. G., M. J. Hickey, J. L. Hardison, M. T. Liu, J. E. Manning, and T. E. Lane. 2004. Antibody targeting of the CC chemokine ligand 5 results in diminished leukocyte infiltration into the central nervous system and reduced neurologic disease in a viral model of multiple sclerosis. J. Immunol. 172: 4018-4025.
21. Nansen, A., I. P. Christensen, S. O. Andreasen, C. Bartholdy, J. E. Christensen, and A. R. Thomsen. 2002. The role of CC chemokine receptor 5 in antiviral immunity. Blood 99: 1237-1245.
22. Trebst, C., S. M. Staugaitis, B. Tucky, T. Wei, K. Suzuki, K. D. Aldape, C. A. Pardo, J. Troncoso, H. Lassmann, and R. M. Ransohoff. 2003. Chemokine receptors on infiltrating leucocytes in inflammatory pathologies of the central nervous system (CNS). Neuropathol. Appl. Neurobiol. 29: 584-595.
23. Kim, C. H., K. Nagata, and E. C. Butcher. 2003. Dendritic cells support sequential reprogramming of chemoattractant receptor profiles during naive to effector T cell differentiation. J. Immunol. 171: 152-158.
24. Kunkel, E. J., J. Boisvert, K. Murphy, M. A. Vierra, M. C. Genovese. A. J. Wardlaw, H. B. Greenberg, M. R. Hodge, L. Wu, E. C. Butcher, and J. J. Campbell. 2002. Expression of the chemokine receptors CCR4, CCR5, and CXCR3 by human tissue-infiltrating lymphocytes. Am. J. Pathol. 160: 347-355.
25. Qin, S. X., J. B. Rottman, P. Myers, N. Kassam, M. Weinblatt, M. Loetscher, A. E. Koch, B. Moser, and C. R. Mackay. 1998. The chemokine receptors CXCR3 and CCR5 mark subsets of T cells associated with certain inflammatory reactions. J. Clin. Invest. 101: 746-754.
26. + T lymphocytes into inflamed joints of rheumatoid arthritis. Int. Immunol. 11: 553-559.
27. Panzer, U., R. R. Reinking, O. M. Steinmetz, G. Zahner, U. Sudbeck, S. Fehr, B. Pfalzer, A. Schneider, F. Thaiss, M. Mack, et al. 2004. CXCR3 and CCR5 positive T cell recruitment in acute human renal allograft rejection. Transplantation 78: 1341-1350.
28. Hancock, W. W., B. Lu, W. Gao, V. Csizmadia, K. Faia, J. A. King, S. T. Smiley, M. Ling, N. P. Gerard, and C. Gerard. 2000. Requirement of the chemokine receptor CXCR3 for acute allograft rejection. J. Exp. Med. 192: 1515-1520.
29. + T cells in cell-mediated immunity to LCMV: studies in MHC class I and class II deficient mice. Scand. J. Immunol. 40: 373-382.
30. Battegay, M., S. Cooper, A. Althage, J, Banziger, H. Hengartner, and R. M. Zinkernagel. 1991. Quantification of lymphocytic choriomeningitis virus with an immunological focus assay in 24-well or 96-well plates. [Published erratum appears in 1991 J. Virol. Methods 35: 115.] J. Virol. Methods 33: 191-198.
31. Andersson, E. C., J. P. Christensen, O. Marker, and A. R. Thomsen, 1994. Changes in cell-adhesion molecule expression on T cells associated with systemic virus infection. J. Immunol. 152: 1237-1245.
32. + T cells but do not induce cell differentiation. Int. Immunol. 11: 1463-1473.
33. + T cells increase during viral infection and migrate to sites of infection. Eur. J. Immunol. 30: 1797-1806.
34. Odermatt, B., M. Eppler, T. P. Leist, H. Hengartner, and R. M. Zinkernagel. 1991. Virus-triggered acquired immunodeficiency by cytotoxic T cell-dependent destruction of antigen-presenting cells and lymph follicle structure. Proc. Natl. Acad. Sci. USA 88: 8252-8256.
35. Doherty, P. C., and R. M. Zinkernagel. 1974. T cell-mediated immunopathology in viral infections. Transplant. Rev. 19: 89-120.
36. + T cells following coronavirus infection of the central nervous system. Virology 312: 407-414.
37. Frigerio, S., T. Junt, B. Lu, C. Gerard, U. Zumsteg, G. A. Hollander, and L. Piali. 2002. β Cells are responsible for CXCR3-mediated T cell infiltration in insulitis. Nat. Med. 8: 1414-1420.
38. Lindow, M., A. Nansen, C. Bartholdy, A. Stryhn, N. J. V. Hansen, T. P. Boesen, T. N. C. Wells, T. W. Schwartz, and A. R. Thomsen. 2003. The virus-encoded chemokine vMIP-II inhibits virus-induced Tel-driven inflammation. J. Virol. 77: 7393-7400.
39. Madsen, A. N., A. Nansen, J. P. Christensen, and A. R. Thomsen. 2003. Role of macrophage inflammatory protein-1α in T cell-mediated immunity to viral infection. J. Virol 77: 12378-12384.
40. + T cells with a type 1 cytokine profile. Int. Immunol. 8: 1453-1461.
41. + T cells varies with activation state and localization, but not with TCR avidity. J. Gen. Virol. 85: 1703-1712.
42. Welniak, L. A., Z. Wang, K. Sun, W. Kuziel, M. R. Anver, B. R. Blazar, and W. J. Murphy. 2004. An absence of CCR5 on donor cells results in acceleration of acute graft-vs-host disease. Exp. Hematol. 32: 318-324.
43. Zhou, Y. H., T. Kurihara, R. P. Ryseck, Y. Yang, C. Ryan, J. Loy, G. Warr, and R. Bravo. 1998. Impaired macrophage function and enhanced T cell-dependent immune response in mice lacking CCR5, the mouse homologue of the major HIV-1 coreceptor. J. Immunol. 160: 4018-4025.
44. Calabresi, P. A., S. H. Yun, R. Allie, and K. A. Whartenby. 2002. Chemokine receptor expression on MBP-reactive T cells: CXCR6 is a marker of IFN-γ-producing effector cells. J. Neuroimmunol. 127: 96-105.
45. + T cells through production of leukotriene B-4. Nat. Immunol. 4: 974-981.
46. Goodarzi, K., M. Goodarzi, A. M. Tager, A. D. Luster, and U. H. von Andrian. 2003. Leukotriene B-4 and BLT1 control cytotoxic effector T cell recruitment to inflamed tissues. Nat. Immunol. 4: 965-973.